松瑞製藥股份有限公司
該股 RSI(6) 為 34.1，處於中性區間，短線無明顯超買超賣訊號。股價站上5日、120日均線，跌破20日、60日均線。KD 指標中性（K=32.2）；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
松瑞製藥股份有限公司（Savior Lifetec Corporation）開發、生產並供應無菌活性醫藥成份（API）及成品藥。專精於培南類（Carbapenem）抗生素，產品包括亞胺培南（Imipenem）、美羅培南（Meropenem）及厄他培南（Ertapenem）。公司成立於 1993 年，總部位於台灣台南。
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 11-10 | +35 | 0 | -53 | -19 |
| 11-09 | -60 | 0 | -8 | -68 |
| 11-06 | +317 | 0 | +34 | +351 |
| 11-05 | -225 | 0 | -8 | -233 |
| 11-04 | +180 | 0 | +16 | +196 |
| 11-03 | -11 | 0 | -11 | -22 |
| 11-02 | -8 | 0 | -20 | -28 |
| 10-30 | +247 | 0 | -13 | +234 |
| 10-29 | +254 | 0 | -4 | +251 |
| 10-28 | -86 | 0 | -12 | -98 |
| 10-27 | -266 | 0 | +4 | -262 |
| 10-22 | +179 | 0 | +2 | +181 |
| 10-21 | +324 | 0 | 0 | +324 |
| 10-20 | +548 | 0 | -5 | +543 |
| 10-19 | -492 | 0 | -21 | -514 |
| 10-16 | +333 | 0 | -22 | +310 |
| 10-15 | +372 | 0 | +106 | +478 |
| 10-14 | -272 | 0 | -124 | -396 |
| 10-13 | -153 | 0 | +65 | -88 |
| 10-12 | -1,303 | 0 | -74 | -1,377 |
| 10-08 | +2,151 | 0 | +148 | +2,298 |
| 10-07 | +1,349 | 0 | +75 | +1,425 |
| 10-06 | +103 | 0 | 0 | +103 |
| 10-05 | -167 | 0 | -10 | -178 |
| 10-02 | +116 | 0 | +11 | +127 |
| 10-01 | -67 | 0 | +3 | -64 |
| 09-30 | +305 | 0 | +16 | +321 |
| 09-29 | +312 | 0 | +15 | +327 |
| 09-24 | -28 | 0 | 0 | -29 |
| 09-23 | +270 | 0 | +9 | +279 |
| 09-22 | +316 | 0 | 0 | +316 |
| 09-21 | +162 | 0 | -5 | +157 |
| 09-18 | +88 | 0 | -2 | +86 |
| 09-17 | +388 | 0 | +7 | +394 |
| 09-16 | +23 | 0 | -4 | +19 |
| 09-15 | +77 | 0 | +1 | +79 |
| 09-14 | +26 | 0 | +2 | +28 |
| 09-11 | -111 | 0 | 0 | -111 |
| 09-10 | -72 | 0 | +2 | -70 |
| 09-09 | -257 | 0 | +2 | -255 |
| 09-08 | -123 | 0 | -1 | -124 |
| 09-07 | -101 | 0 | -13 | -114 |
| 09-04 | -166 | 0 | -2 | -168 |
| 09-03 | -372 | 0 | -13 | -385 |
| 09-02 | -109 | 0 | -4 | -113 |
| 09-01 | -354 | 0 | -24 | -378 |
| 08-31 | -358 | 0 | -28 | -386 |
| 08-28 | -119 | 0 | -14 | -133 |
| 08-27 | -28 | 0 | +18 | -9 |
| 08-26 | +26 | 0 | -3 | +23 |
| 08-25 | -112 | 0 | -36 | -148 |
| 08-24 | +139 | 0 | -87 | +52 |
| 08-21 | +801 | 0 | -5 | +796 |
| 08-20 | +1,816 | 0 | +35 | +1,851 |
| 08-19 | +679 | 0 | +5 | +684 |
| 08-18 | +178 | 0 | -7 | +171 |
| 08-17 | -9 | 0 | +3 | -6 |
| 08-14 | +365 | 0 | +40 | +405 |
| 08-13 | -61 | 0 | -9 | -69 |
| 08-12 | -188 | 0 | -14 | -202 |
| 08-11 | -225 | 0 | 0 | -225 |
| 08-10 | -969 | 0 | +36 | -933 |
| 08-07 | +1,064 | 0 | +56 | +1,120 |
| 08-06 | +22 | 0 | -4 | +18 |
| 08-05 | -167 | 0 | -24 | -191 |
| 08-04 | +102 | 0 | +24 | +126 |
| 08-03 | -286 | 0 | +12 | -273 |
| 07-31 | -363 | 0 | -4 | -366 |
| 07-30 | -499 | 0 | -70 | -569 |
| 07-29 | -765 | 0 | -17 | -782 |
| 07-28 | -1,046 | 0 | -39 | -1,085 |
| 07-27 | +36 | 0 | +14 | +50 |
| 07-24 | +37 | 0 | -3 | +34 |
| 07-23 | -34 | 0 | +4 | -30 |
| 07-22 | -118 | 0 | -1 | -119 |
| 07-21 | +127 | 0 | +1 | +128 |
| 07-20 | +60 | 0 | -24 | +35 |
| 07-17 | -412 | 0 | +9 | -403 |
| 07-16 | +569 | 0 | +19 | +588 |
| 07-15 | +421 | 0 | +8 | +430 |
| 07-14 | +98 | 0 | -54 | +44 |
| 07-13 | +20 | 0 | -19 | 0 |
| 07-09 | +16 | 0 | -5 | +11 |
| 07-08 | +113 | 0 | +14 | +128 |
| 07-07 | +940 | 0 | +19 | +959 |
| 07-06 | +537 | 0 | +9 | +546 |
| 07-03 | +767 | 0 | +13 | +780 |
| 07-02 | -77 | 0 | -23 | -100 |
| 07-01 | +233 | 0 | 0 | +234 |
| 06-30 | +317 | 0 | -3 | +314 |
| 06-29 | +787 | 0 | +16 | +803 |
| 06-26 | -265 | 0 | -7 | -272 |
| 06-25 | +102 | 0 | -1 | +101 |
| 06-24 | +258 | 0 | -11 | +248 |
| 06-23 | -605 | 0 | -5 | -610 |
| 06-22 | -383 | 0 | -18 | -401 |
| 06-18 | +230 | 0 | -1 | +229 |
| 06-17 | -54 | 0 | 0 | -55 |
| 06-16 | -79 | 0 | -10 | -89 |
| 06-15 | -54 | 0 | +1 | -53 |
| 06-12 | +235 | 0 | 0 | +235 |
| 06-11 | -6 | 0 | -2 | -8 |
| 06-10 | +26 | 0 | +1 | +27 |
| 06-09 | +144 | 0 | +6 | +150 |
| 06-08 | +273 | 0 | -1 | +273 |
| 06-05 | +298 | 0 | +16 | +314 |
| 06-04 | +723 | 0 | +34 | +757 |
| 06-03 | +189 | 0 | -6 | +183 |
| 06-02 | +171 | 0 | +5 | +176 |
| 06-01 | +283 | 0 | +17 | +300 |
| 05-29 | +293 | 0 | +53 | +346 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/10 | 1.36 億 | +30.8% | +21.3% |
| 2026/09 | 1.04 億 | -11.2% | +33.7% |
| 2026/08 | 1.17 億 | +20.2% | +22.3% |
| 2026/07 | 9748 萬 | -4.7% | -10.4% |
| 2026/06 | 1.02 億 | +16.2% | -0.2% |
| 2026/05 | 8798 萬 | -8.1% | -23.0% |
| 2026/04 | 9569 萬 | +12.1% | -19.4% |
| 2026/03 | 8535 萬 | +32.6% | -9.1% |
| 2026/02 | 6436 萬 | -23.2% | -10.9% |
| 2026/01 | 8386 萬 | -30.0% | -14.2% |
| 2025/12 | 1.20 億 | +36.3% | +106.7% |
| 2025/11 | 8786 萬 | - | -23.8% |